A DECISION MODELING APPROACH TO EVALUATE THE COST-EFFECTIVENESS OF PRASUGREL VERSUS CLOPIDOGREL IN PATIENTS WITH PLANNED PERCUTANEOUS CORONARY INTERVENTION

被引：1
|
作者：
Rao, S. [1 ]
Lin, F. J. [1 ]
Ojo, O. [1 ]
Patel, V [1 ]
Yu, S. [1 ]
Zhan, L. [1 ]
Touchette, D. R. [1 ]
机构：
[1] Univ Illinois, Chicago, IL USA
来源：
VALUE IN HEALTH | 2011年 / 14卷 / 03期
关键词：
D O I：
10.1016/j.jval.2011.02.229
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A39 / A40
页数：2
相关论文
共 50 条
  • [1] Cost-effectiveness of prasugrel versus clopidogrel in acute coronary syndrome patients undergoing percutaneous coronary intervention
    Spartalis, Michael
    Tzatzaki, Eleni
    Nikiteas, Nikolaos I.
    Spartalis, Eleftherios
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2018, 251 : 32 - 32
  • [2] COST-EFFECTIVENESS OF PRASUGREL VERSUS CLOPIDOGREL IN PATIENTS WITH ACUTE CORONARY SYNDROMES UNDERGOING PERCUTANEOUS CORONARY INTERVENTION IN THE PRIVATE SECTOR IN MEXICO
    Mondragon, R.
    Arrieta-Maturino, E.
    Vargas-Valencia, J. J.
    Ramirez-Gamez, J.
    Martinez-Fonseca, J.
    Guzman-Sotelo, M.
    VALUE IN HEALTH, 2011, 14 (07) : A535 - A535
  • [3] CLOPIDOGREL VERSUS PRASUGREL IN PATIENTS UNDERGOING ELECTIVE PERCUTANEOUS CORONARY INTERVENTION
    Zeb, Shah
    Shah, Ibrahim
    Adil, Mohammad
    Ali, Jabar
    Jan, Hikmatullah
    Gul, Adnan Mahmood
    Hafizullah, Mohammad
    PAKISTAN HEART JOURNAL, 2016, 49 (03): : 107 - 112
  • [4] Prasugrel versus clopidogrel in acute coronary syndrome patients undergoing percutaneous coronary intervention
    Deepak L. Bhatt
    Current Atherosclerosis Reports, 2008, 10 (5) : 367 - 368
  • [5] Ticagrelor or prasugrel versus clopidogrel in patients undergoing percutaneous coronary intervention for chronic coronary syndromes
    Koshy, Anoop N.
    Giustino, Gennaro
    Sartori, Samantha
    Hooda, Amit
    Feng, Yihan
    Snyder, Clayton
    Dasgupta, Shabitri
    Kumar, Kartik R.
    Krishnamoorthy-Melarcode, Parasuram
    Sweeny, Joseph
    Khera, Sahil
    Serrao, Gregory W.
    Sharma, Raman
    Dangas, George
    Kini, Annapoorna S.
    Mehran, Roxana
    Sharma, Samin K.
    EUROINTERVENTION, 2023, 18 (15) : 1244 - +
  • [6] Cost-Effectiveness of Prasugrel Versus Clopidogrel in Patients With Acute Coronary Syndromes and Planned Percutaneous Coronary Intervention Results From the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel-Thrombolysis in Myocardial Infarction TRITON-TIMI 38
    Mahoney, Elizabeth M.
    Wang, Kaijun
    Arnold, Suzanne V.
    Proskorovsky, Irina
    Wiviott, Stephen
    Antman, Elliott
    Braunwald, Eugene
    Cohen, David J.
    CIRCULATION, 2010, 121 (01) : 71 - U99
  • [7] The cost-effectiveness of clopidogrel in patients undergoing percutaneous coronary intervention in Sweden:: An analysis of PCI-cure
    Lindgren, P
    Stenestrand, U
    Malmberg, K
    Jönsson, B
    VALUE IN HEALTH, 2004, 7 (06) : 688 - 688
  • [8] Cost-effectiveness analysis of intravascular ultrasound guided percutaneous coronary intervention versus conventional percutaneous coronary intervention
    Gaster, AL
    Slothuus, U
    Larsen, J
    Thayssen, P
    Haghfelt, T
    SCANDINAVIAN CARDIOVASCULAR JOURNAL, 2001, 35 (02) : 80 - 85
  • [9] COST-EFFECTIVENESS OF PRASUGREL VERSUS CLOPIDOGREL IN PATIENTS WITH ACUTE CORONARY SYNDROMES AND PLANNED PCI: RESULTS FROM THE TRITON-TIMI 38 TRIAL FROM THE GERMAN PERSPECTIVE
    Mahoney, E. M.
    Wang, K.
    McCollam, P. L.
    Schmitt, C.
    Cohen, D. J.
    VALUE IN HEALTH, 2009, 12 (07) : A328 - A329
  • [10] Cost-effectiveness analysis of pharmacogenomics-guided clopidogrel treatment in Spanish patients undergoing percutaneous coronary intervention
    Vasilios Fragoulakis
    Marina Bartsakoulia
    Xando Díaz-Villamarín
    Konstantina Chalikiopoulou
    Konstantina Kehagia
    Jesús Gabriel Sánchez Ramos
    Luis Javier Martínez-González
    Maria Gkotsi
    Eva Katrali
    Efthimios Skoufas
    Athanassios Vozikis
    Anne John
    Bassam R. Ali
    Sarah Wordsworth
    Cristina L. Dávila-Fajardo
    Theodora Katsila
    George P. Patrinos
    Christina Mitropoulou
    The Pharmacogenomics Journal, 2019, 19 : 438 - 445
12345